Pentech Pharmaceuticals, Inc.
19Patents
0Active
19Granted
30Portfolio score
Filing activity: Dec 23, 1994 → Oct 23, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5624677A | Controlled release of drugs delivered by sublingual or buccal administration | Human Necessities | 99 | Expired |
| US5939094A | Transdermal administration of apomorphine | Human Necessities | 54 | Expired |
| US5770606A | Dosage forms and method for ameliorating male erectile dysfunction | Human Necessities | 50 | Expired |
| US6087362A | Apomorphine and sildenafil composition | Human Necessities | 48 | Expired |
| US5945117A | Treatment of female sexual dysfunction | Human Necessities | 41 | Expired |
| US5888534A | Controlled release of drugs delivered by sublingual or buccal administration | Human Necessities | 31 | Expired |
| US5562917A | Transdermal administration of apomorphine | Human Necessities | 29 | Expired |
| US6193992A | Female sexual dysfunction treatment | Human Necessities | 28 | Expired |
| US5994363A | Amelioration of apomorphine adverse effects | Human Necessities | 27 | Expired |
| US5672612A | Amorphous paroxetine composition | Human Necessities | 25 | Expired |
| US6121276A | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction | Human Necessities | 23 | Expired |
| US6306437A | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction | Human Necessities | 20 | Expired |
| US6200983A | Dosage forms containing apomorphine for ameliorating male erectile dysfunction | Human Necessities | 17 | Expired |
| US6566368B2 | Apomorphine-containing dosage form for ameliorating male erectile dysfunction | Human Necessities | 17 | Expired |
| US5830500A | Low dose fluoxetine tablet | Human Necessities | 7 | Expired |
| US6503927B1 | Amorphous paroxetine composition | Human Necessities | 6 | Expired |
| US6660298B1 | Paroxetine tablets and capsules | Human Necessities | 5 | Expired |
| US5985889A | Dosage forms and method for ameliorating male erectile dysfunction | Human Necessities | 3 | Expired |
| US6638948B1 | Amorphous paroxetine composition | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.